CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities:
Net loss	$ (117,163)	$ (104,139)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	29,819	17,986
Stock-based compensation	30,464	26,724
Amortization of debt discount and debt issuance costs	1,470	1,589
Amortization of right-of-use assets	1,927	2,730
Write-down for excess and obsolete inventories	7,023	6,842
Loss on disposal of assets	1,739	969
Loss on extinguishment of debt, net		7,434
Other	573	861
Changes in operating assets and liabilities:
Accounts receivable	(10,133)	(1,417)
Inventories	(20,131)	(23,817)
Prepaid expenses and other current assets	19	4,815
Other assets	(840)	69
Accounts payable	7,437	(298)
Accrued expenses	4,144	258
Lease liabilities	(1,905)	168
Contract liabilities	(1,133)	(3,601)
Other long-term liabilities	(50)	4,251
Net cash used in operating activities	(66,740)	(58,576)
Investing activities:
Purchase of property and equipment	(35,984)	(48,946)
Purchase of intangible assets	(7,461)
Acquisition of business, net of cash acquired		(62,133)
Purchase of OCEANE		(21,097)
Cash paid for investments		(3,000)
Settlement of forward contract		(2,589)
Net cash used in investing activities	(43,445)	(137,765)
Financing activities:
Proceeds from Revolving Credit Facility	35,000
Payment of debt issuance costs	(968)	(10,028)
Proceeds from common stock offering		131,828
Proceeds from issuance of convertible notes		316,250
Net cash paid from common stock exercises	(4,179)	(5,825)
Purchase of capped calls		(39,866)
Repurchase of common stock		(25,000)
Repayment of Squadron Medical term loan		(45,000)
Proceeds from financed insurance	1,801
Repayment of Inventory Financing Agreement		(8,088)
Principal payments on finance lease obligations	(126)	(65)
Principal payments on term loan and notes payable	(1,313)	(1,545)
Other		(208)
Net cash provided by financing activities	30,215	312,453
Effect of exchange rate changes on cash	(1,166)	(9)
Net (decrease) increase in cash and cash equivalents	(81,136)	116,103
Cash and cash equivalents at beginning of period	187,248	107,765
Cash and cash equivalents at end of period	106,112	223,868
Supplemental disclosure of cash flow information:
Cash paid for interest	2,723	4,297
Cash paid for income taxes	272	225
Supplemental disclosure of noncash activities:
PPP Loan Forgiveness		4,271
Financed insurance	1,801
Financed inventory		4,015
Debt issuance costs	347
Purchases of property and equipment in accounts payable and accrued expenses	2,019	4,459
Purchase of intangible assets	750
Recognition of lease liability	180	$ 23,403
Modification of lease liability for lease amendment	4,288
Common stock issued for asset acquisition	$ 250